Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

May 01, 2011 (Vol. 31, No. 9)

Cell Therapy Building on Momentum

Success of Dendreon's Provenge Illuminates Possibilities in this Fast-Growing Field

  • Cell therapy for regenerative medicine is here, “but at the moment what we are offering is first-generation cell products,” said Nagy Habib, M.D., CEO of LiverCyte and head of HPB surgery at London’s Hammersmith Hospital, at the recent “International Business Innovation Zone” (IBIZ) conference. “We have the bike now, ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.